IV Versus Subcutaneous Enoxaparin in Critically Ill Infants and Children: Comparison of Dosing, Anticoagulation Quality, Efficacy, and Safety Outcomes* - Concepedia

Concepedia

Publication | Closed Access

IV Versus Subcutaneous Enoxaparin in Critically Ill Infants and Children: Comparison of Dosing, Anticoagulation Quality, Efficacy, and Safety Outcomes*

16

Citations

19

References

2017

Year

Yaser Diab, Karthik Ramakrishnan, Brandon E. Ferrell, Reginald Chounoune, Fahad A. Alfares, Kendal M. Endicott, Sara P. Rooney, Jason Corcoran, David Zurakowski, John Berger,

Pediatric Critical Care Medicine

Abstract

Our study suggests that anticoagulation with IV enoxaparin infused over 30 minutes is a safe and an equally effective alternative to subcutaneous enoxaparin in critically ill infants and children.

References

	Year	Citations

Page 1